Very low-certainty evidence means that we were uncertain about the result. Conclusion A two-dose schedule of HPV vaccines in young females results in immune system responses that are comparable with a ...

Our study is the first to provide a comprehensive national update on HPV infection dynamics across all 32 states of Mexico, involving a large cohort of women which enhances the robustness of our ...

For this, large clinical trials over several years were required, despite the fact that infections by HPV-16 and -18 are very common. [62–68] Today, we know that both vaccines provide close to ...

One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...

The policy adopted by China aligns with the WHO’s guidelines for standard HPV vaccination among those aged 9–14. 22 However, China’s vaccination programme only covers limited age groups, leaving those ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...

Objectives Identifying factors associated with human papillomavirus (HPV) vaccine uptake is essential for designing successful vaccination programmes. We aimed to examine the association between ...

Harper DM et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet ...

If you're not sure where to start, here's a list of people and organizations you can reach out to: Ask your parents or other caregivers if they've kept records of your immunizations from childhood ...

Researchers say the vaccine, developed by Anixa Biosciences and funded by the Department of Defense, could eliminate breast cancer - which one out of eight women will get in her life - by 2030.

Specifically, the human papillomavirus (HPV) vaccine is a significant advancement in reducing women’s risk of cervical cancer. 1 The World Health Organization’s (WHO) new guidelines, published in 2020 ...